Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-125.27	-34.76	-15.43
Graham Fair Price	-27.37	1.45	2.00
PEG	1055.18	0.06	< 0.005
Price/Book	-26.89	0.24	0.33
Price/Cash Flow	-80.31	-4.71	23.90
Prices/Earnings	-94.33	-3.58	-1.84
Price/Sales	-13.52	0.62	0.71
Price/FCF	-80.31	-4.71	23.90
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	65.67	-0.02	-0.06
Operating Margin	64.98	-0.04	-0.12
ROA	62.88	< 0.005	-0.02
ROE	-0.05	-0.02	62.38
ROIC	-0.04	-0.01	66.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.03	51.97
Dividends QOQ	-0.60	0.81	34.81
EBIT QOQ	-6.01	0.71	-88.20
EPS QOQ	-3.30	0.55	-83.18
FCF QOQ	2.99	-4.65	55.55
Revenue QOQ	0.03	-0.17	429.12
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	23.90	36.53	52.87
Days Sales Outstanding (DSO)	12.73	18.35	44.11
Inventory Turnover	3.77	2.46	-34.59
Debt/Capitalization	0.23	0.24	5.10
Quick Ratio	0.23	0.18	-25.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.98	2.34	18.42
Cash	0.19	0.11	-41.32
Capex	-0.03	-0.02	14.92
Free Cash Flow	0.03	-0.12	339.73
Revenue	0.93	0.93	0.11
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.44	0.42	-3.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.74	-18.15	-216.11
Naive Interpretation	Member

06 - Financial Health · Bad

Rating